Global Oligonucleotide API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Oligonucleotide API Industry Forecast” looks at past sales and reviews total world Oligonucleotide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligonucleotide API sales for 2023 through 2029. With Oligonucleotide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide API industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oligonucleotide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide API.
The global Oligonucleotide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oligonucleotide API players cover Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Oligonucleotide API market?
What factors are driving Oligonucleotide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide API market opportunities vary by end market size?
How does Oligonucleotide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Oligonucleotide API Industry Forecast” looks at past sales and reviews total world Oligonucleotide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligonucleotide API sales for 2023 through 2029. With Oligonucleotide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide API industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oligonucleotide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide API.
The global Oligonucleotide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oligonucleotide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oligonucleotide API players cover Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Antisense Oligonucleotides API
- Small Interfering RNA (siRNA) API
- MiRNA API
- CpG Oligonucleotides API
- Others
- Contract Manufacturing Organizations (CMOs)
- Pharmaceutical Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jazz Pharmaceuticals
- Sarepta Therapeutics
- Biogen
- Dynavax Technologies
- Akcea Therapeutics
- Alnylam Pharmaceuticals
- Nitto Denko (Avecia)
- Ajinomoto (GeneDesign)
- RiboBio
What is the 10-year outlook for the global Oligonucleotide API market?
What factors are driving Oligonucleotide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide API market opportunities vary by end market size?
How does Oligonucleotide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oligonucleotide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oligonucleotide API by Country/Region, 2018, 2022 & 2029
2.2 Oligonucleotide API Segment by Type
2.2.1 Antisense Oligonucleotides API
2.2.2 Small Interfering RNA (siRNA) API
2.2.3 MiRNA API
2.2.4 CpG Oligonucleotides API
2.2.5 Others
2.3 Oligonucleotide API Sales by Type
2.3.1 Global Oligonucleotide API Sales Market Share by Type (2018-2023)
2.3.2 Global Oligonucleotide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oligonucleotide API Sale Price by Type (2018-2023)
2.4 Oligonucleotide API Segment by Application
2.4.1 Contract Manufacturing Organizations (CMOs)
2.4.2 Pharmaceutical Companies
2.5 Oligonucleotide API Sales by Application
2.5.1 Global Oligonucleotide API Sale Market Share by Application (2018-2023)
2.5.2 Global Oligonucleotide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oligonucleotide API Sale Price by Application (2018-2023)
3 GLOBAL OLIGONUCLEOTIDE API BY COMPANY
3.1 Global Oligonucleotide API Breakdown Data by Company
3.1.1 Global Oligonucleotide API Annual Sales by Company (2018-2023)
3.1.2 Global Oligonucleotide API Sales Market Share by Company (2018-2023)
3.2 Global Oligonucleotide API Annual Revenue by Company (2018-2023)
3.2.1 Global Oligonucleotide API Revenue by Company (2018-2023)
3.2.2 Global Oligonucleotide API Revenue Market Share by Company (2018-2023)
3.3 Global Oligonucleotide API Sale Price by Company
3.4 Key Manufacturers Oligonucleotide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide API Product Location Distribution
3.4.2 Players Oligonucleotide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE API BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Oligonucleotide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oligonucleotide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oligonucleotide API Market Size by Country/Region (2018-2023)
4.2.1 Global Oligonucleotide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oligonucleotide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oligonucleotide API Sales Growth
4.4 APAC Oligonucleotide API Sales Growth
4.5 Europe Oligonucleotide API Sales Growth
4.6 Middle East & Africa Oligonucleotide API Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide API Sales by Country
5.1.1 Americas Oligonucleotide API Sales by Country (2018-2023)
5.1.2 Americas Oligonucleotide API Revenue by Country (2018-2023)
5.2 Americas Oligonucleotide API Sales by Type
5.3 Americas Oligonucleotide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide API Sales by Region
6.1.1 APAC Oligonucleotide API Sales by Region (2018-2023)
6.1.2 APAC Oligonucleotide API Revenue by Region (2018-2023)
6.2 APAC Oligonucleotide API Sales by Type
6.3 APAC Oligonucleotide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide API by Country
7.1.1 Europe Oligonucleotide API Sales by Country (2018-2023)
7.1.2 Europe Oligonucleotide API Revenue by Country (2018-2023)
7.2 Europe Oligonucleotide API Sales by Type
7.3 Europe Oligonucleotide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide API by Country
8.1.1 Middle East & Africa Oligonucleotide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oligonucleotide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Oligonucleotide API Sales by Type
8.3 Middle East & Africa Oligonucleotide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide API
10.3 Manufacturing Process Analysis of Oligonucleotide API
10.4 Industry Chain Structure of Oligonucleotide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide API Distributors
11.3 Oligonucleotide API Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE API BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide API Market Size Forecast by Region
12.1.1 Global Oligonucleotide API Forecast by Region (2024-2029)
12.1.2 Global Oligonucleotide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oligonucleotide API Forecast by Type
12.7 Global Oligonucleotide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Jazz Pharmaceuticals
13.1.1 Jazz Pharmaceuticals Company Information
13.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
13.1.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Jazz Pharmaceuticals Main Business Overview
13.1.5 Jazz Pharmaceuticals Latest Developments
13.2 Sarepta Therapeutics
13.2.1 Sarepta Therapeutics Company Information
13.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolios and Specifications
13.2.3 Sarepta Therapeutics Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sarepta Therapeutics Main Business Overview
13.2.5 Sarepta Therapeutics Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Oligonucleotide API Product Portfolios and Specifications
13.3.3 Biogen Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Dynavax Technologies
13.4.1 Dynavax Technologies Company Information
13.4.2 Dynavax Technologies Oligonucleotide API Product Portfolios and Specifications
13.4.3 Dynavax Technologies Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dynavax Technologies Main Business Overview
13.4.5 Dynavax Technologies Latest Developments
13.5 Akcea Therapeutics
13.5.1 Akcea Therapeutics Company Information
13.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolios and Specifications
13.5.3 Akcea Therapeutics Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Akcea Therapeutics Main Business Overview
13.5.5 Akcea Therapeutics Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
13.6.3 Alnylam Pharmaceuticals Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Nitto Denko (Avecia)
13.7.1 Nitto Denko (Avecia) Company Information
13.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolios and Specifications
13.7.3 Nitto Denko (Avecia) Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nitto Denko (Avecia) Main Business Overview
13.7.5 Nitto Denko (Avecia) Latest Developments
13.8 Ajinomoto (GeneDesign)
13.8.1 Ajinomoto (GeneDesign) Company Information
13.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolios and Specifications
13.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ajinomoto (GeneDesign) Main Business Overview
13.8.5 Ajinomoto (GeneDesign) Latest Developments
13.9 RiboBio
13.9.1 RiboBio Company Information
13.9.2 RiboBio Oligonucleotide API Product Portfolios and Specifications
13.9.3 RiboBio Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 RiboBio Main Business Overview
13.9.5 RiboBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oligonucleotide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oligonucleotide API by Country/Region, 2018, 2022 & 2029
2.2 Oligonucleotide API Segment by Type
2.2.1 Antisense Oligonucleotides API
2.2.2 Small Interfering RNA (siRNA) API
2.2.3 MiRNA API
2.2.4 CpG Oligonucleotides API
2.2.5 Others
2.3 Oligonucleotide API Sales by Type
2.3.1 Global Oligonucleotide API Sales Market Share by Type (2018-2023)
2.3.2 Global Oligonucleotide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oligonucleotide API Sale Price by Type (2018-2023)
2.4 Oligonucleotide API Segment by Application
2.4.1 Contract Manufacturing Organizations (CMOs)
2.4.2 Pharmaceutical Companies
2.5 Oligonucleotide API Sales by Application
2.5.1 Global Oligonucleotide API Sale Market Share by Application (2018-2023)
2.5.2 Global Oligonucleotide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oligonucleotide API Sale Price by Application (2018-2023)
3 GLOBAL OLIGONUCLEOTIDE API BY COMPANY
3.1 Global Oligonucleotide API Breakdown Data by Company
3.1.1 Global Oligonucleotide API Annual Sales by Company (2018-2023)
3.1.2 Global Oligonucleotide API Sales Market Share by Company (2018-2023)
3.2 Global Oligonucleotide API Annual Revenue by Company (2018-2023)
3.2.1 Global Oligonucleotide API Revenue by Company (2018-2023)
3.2.2 Global Oligonucleotide API Revenue Market Share by Company (2018-2023)
3.3 Global Oligonucleotide API Sale Price by Company
3.4 Key Manufacturers Oligonucleotide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide API Product Location Distribution
3.4.2 Players Oligonucleotide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE API BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Oligonucleotide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oligonucleotide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oligonucleotide API Market Size by Country/Region (2018-2023)
4.2.1 Global Oligonucleotide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oligonucleotide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oligonucleotide API Sales Growth
4.4 APAC Oligonucleotide API Sales Growth
4.5 Europe Oligonucleotide API Sales Growth
4.6 Middle East & Africa Oligonucleotide API Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide API Sales by Country
5.1.1 Americas Oligonucleotide API Sales by Country (2018-2023)
5.1.2 Americas Oligonucleotide API Revenue by Country (2018-2023)
5.2 Americas Oligonucleotide API Sales by Type
5.3 Americas Oligonucleotide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide API Sales by Region
6.1.1 APAC Oligonucleotide API Sales by Region (2018-2023)
6.1.2 APAC Oligonucleotide API Revenue by Region (2018-2023)
6.2 APAC Oligonucleotide API Sales by Type
6.3 APAC Oligonucleotide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide API by Country
7.1.1 Europe Oligonucleotide API Sales by Country (2018-2023)
7.1.2 Europe Oligonucleotide API Revenue by Country (2018-2023)
7.2 Europe Oligonucleotide API Sales by Type
7.3 Europe Oligonucleotide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide API by Country
8.1.1 Middle East & Africa Oligonucleotide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oligonucleotide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Oligonucleotide API Sales by Type
8.3 Middle East & Africa Oligonucleotide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide API
10.3 Manufacturing Process Analysis of Oligonucleotide API
10.4 Industry Chain Structure of Oligonucleotide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide API Distributors
11.3 Oligonucleotide API Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE API BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide API Market Size Forecast by Region
12.1.1 Global Oligonucleotide API Forecast by Region (2024-2029)
12.1.2 Global Oligonucleotide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oligonucleotide API Forecast by Type
12.7 Global Oligonucleotide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Jazz Pharmaceuticals
13.1.1 Jazz Pharmaceuticals Company Information
13.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
13.1.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Jazz Pharmaceuticals Main Business Overview
13.1.5 Jazz Pharmaceuticals Latest Developments
13.2 Sarepta Therapeutics
13.2.1 Sarepta Therapeutics Company Information
13.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolios and Specifications
13.2.3 Sarepta Therapeutics Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sarepta Therapeutics Main Business Overview
13.2.5 Sarepta Therapeutics Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Oligonucleotide API Product Portfolios and Specifications
13.3.3 Biogen Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Dynavax Technologies
13.4.1 Dynavax Technologies Company Information
13.4.2 Dynavax Technologies Oligonucleotide API Product Portfolios and Specifications
13.4.3 Dynavax Technologies Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dynavax Technologies Main Business Overview
13.4.5 Dynavax Technologies Latest Developments
13.5 Akcea Therapeutics
13.5.1 Akcea Therapeutics Company Information
13.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolios and Specifications
13.5.3 Akcea Therapeutics Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Akcea Therapeutics Main Business Overview
13.5.5 Akcea Therapeutics Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
13.6.3 Alnylam Pharmaceuticals Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Nitto Denko (Avecia)
13.7.1 Nitto Denko (Avecia) Company Information
13.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolios and Specifications
13.7.3 Nitto Denko (Avecia) Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nitto Denko (Avecia) Main Business Overview
13.7.5 Nitto Denko (Avecia) Latest Developments
13.8 Ajinomoto (GeneDesign)
13.8.1 Ajinomoto (GeneDesign) Company Information
13.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolios and Specifications
13.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ajinomoto (GeneDesign) Main Business Overview
13.8.5 Ajinomoto (GeneDesign) Latest Developments
13.9 RiboBio
13.9.1 RiboBio Company Information
13.9.2 RiboBio Oligonucleotide API Product Portfolios and Specifications
13.9.3 RiboBio Oligonucleotide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 RiboBio Main Business Overview
13.9.5 RiboBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oligonucleotide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oligonucleotide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides API
Table 4. Major Players of Small Interfering RNA (siRNA) API
Table 5. Major Players of MiRNA API
Table 6. Major Players of CpG Oligonucleotides API
Table 7. Major Players of Others
Table 8. Global Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 9. Global Oligonucleotide API Sales Market Share by Type (2018-2023)
Table 10. Global Oligonucleotide API Revenue by Type (2018-2023) & ($ million)
Table 11. Global Oligonucleotide API Revenue Market Share by Type (2018-2023)
Table 12. Global Oligonucleotide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 14. Global Oligonucleotide API Sales Market Share by Application (2018-2023)
Table 15. Global Oligonucleotide API Revenue by Application (2018-2023)
Table 16. Global Oligonucleotide API Revenue Market Share by Application (2018-2023)
Table 17. Global Oligonucleotide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Oligonucleotide API Sales by Company (2018-2023) & (Ton)
Table 19. Global Oligonucleotide API Sales Market Share by Company (2018-2023)
Table 20. Global Oligonucleotide API Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Oligonucleotide API Revenue Market Share by Company (2018-2023)
Table 22. Global Oligonucleotide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Oligonucleotide API Producing Area Distribution and Sales Area
Table 24. Players Oligonucleotide API Products Offered
Table 25. Oligonucleotide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oligonucleotide API Sales by Geographic Region (2018-2023) & (Ton)
Table 29. Global Oligonucleotide API Sales Market Share Geographic Region (2018-2023)
Table 30. Global Oligonucleotide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Oligonucleotide API Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Oligonucleotide API Sales by Country/Region (2018-2023) & (Ton)
Table 33. Global Oligonucleotide API Sales Market Share by Country/Region (2018-2023)
Table 34. Global Oligonucleotide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Oligonucleotide API Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 37. Americas Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 38. Americas Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 40. Americas Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 41. Americas Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 42. APAC Oligonucleotide API Sales by Region (2018-2023) & (Ton)
Table 43. APAC Oligonucleotide API Sales Market Share by Region (2018-2023)
Table 44. APAC Oligonucleotide API Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Oligonucleotide API Revenue Market Share by Region (2018-2023)
Table 46. APAC Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 47. APAC Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 48. Europe Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 49. Europe Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 50. Europe Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 52. Europe Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 53. Europe Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 54. Middle East & Africa Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 55. Middle East & Africa Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 59. Middle East & Africa Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 60. Key Market Drivers & Growth Opportunities of Oligonucleotide API
Table 61. Key Market Challenges & Risks of Oligonucleotide API
Table 62. Key Industry Trends of Oligonucleotide API
Table 63. Oligonucleotide API Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oligonucleotide API Distributors List
Table 66. Oligonucleotide API Customer List
Table 67. Global Oligonucleotide API Sales Forecast by Region (2024-2029) & (Ton)
Table 68. Global Oligonucleotide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 70. Americas Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Oligonucleotide API Sales Forecast by Region (2024-2029) & (Ton)
Table 72. APAC Oligonucleotide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 74. Europe Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 76. Middle East & Africa Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Oligonucleotide API Sales Forecast by Type (2024-2029) & (Ton)
Table 78. Global Oligonucleotide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Oligonucleotide API Sales Forecast by Application (2024-2029) & (Ton)
Table 80. Global Oligonucleotide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Jazz Pharmaceuticals Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 82. Jazz Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
Table 83. Jazz Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. Jazz Pharmaceuticals Main Business
Table 85. Jazz Pharmaceuticals Latest Developments
Table 86. Sarepta Therapeutics Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 87. Sarepta Therapeutics Oligonucleotide API Product Portfolios and Specifications
Table 88. Sarepta Therapeutics Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Sarepta Therapeutics Main Business
Table 90. Sarepta Therapeutics Latest Developments
Table 91. Biogen Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 92. Biogen Oligonucleotide API Product Portfolios and Specifications
Table 93. Biogen Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Biogen Main Business
Table 95. Biogen Latest Developments
Table 96. Dynavax Technologies Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 97. Dynavax Technologies Oligonucleotide API Product Portfolios and Specifications
Table 98. Dynavax Technologies Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Dynavax Technologies Main Business
Table 100. Dynavax Technologies Latest Developments
Table 101. Akcea Therapeutics Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 102. Akcea Therapeutics Oligonucleotide API Product Portfolios and Specifications
Table 103. Akcea Therapeutics Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. Akcea Therapeutics Main Business
Table 105. Akcea Therapeutics Latest Developments
Table 106. Alnylam Pharmaceuticals Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 107. Alnylam Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
Table 108. Alnylam Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Alnylam Pharmaceuticals Main Business
Table 110. Alnylam Pharmaceuticals Latest Developments
Table 111. Nitto Denko (Avecia) Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 112. Nitto Denko (Avecia) Oligonucleotide API Product Portfolios and Specifications
Table 113. Nitto Denko (Avecia) Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Nitto Denko (Avecia) Main Business
Table 115. Nitto Denko (Avecia) Latest Developments
Table 116. Ajinomoto (GeneDesign) Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 117. Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolios and Specifications
Table 118. Ajinomoto (GeneDesign) Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Ajinomoto (GeneDesign) Main Business
Table 120. Ajinomoto (GeneDesign) Latest Developments
Table 121. RiboBio Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 122. RiboBio Oligonucleotide API Product Portfolios and Specifications
Table 123. RiboBio Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. RiboBio Main Business
Table 125. RiboBio Latest Developments
Table 1. Oligonucleotide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oligonucleotide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides API
Table 4. Major Players of Small Interfering RNA (siRNA) API
Table 5. Major Players of MiRNA API
Table 6. Major Players of CpG Oligonucleotides API
Table 7. Major Players of Others
Table 8. Global Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 9. Global Oligonucleotide API Sales Market Share by Type (2018-2023)
Table 10. Global Oligonucleotide API Revenue by Type (2018-2023) & ($ million)
Table 11. Global Oligonucleotide API Revenue Market Share by Type (2018-2023)
Table 12. Global Oligonucleotide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 14. Global Oligonucleotide API Sales Market Share by Application (2018-2023)
Table 15. Global Oligonucleotide API Revenue by Application (2018-2023)
Table 16. Global Oligonucleotide API Revenue Market Share by Application (2018-2023)
Table 17. Global Oligonucleotide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Oligonucleotide API Sales by Company (2018-2023) & (Ton)
Table 19. Global Oligonucleotide API Sales Market Share by Company (2018-2023)
Table 20. Global Oligonucleotide API Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Oligonucleotide API Revenue Market Share by Company (2018-2023)
Table 22. Global Oligonucleotide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Oligonucleotide API Producing Area Distribution and Sales Area
Table 24. Players Oligonucleotide API Products Offered
Table 25. Oligonucleotide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oligonucleotide API Sales by Geographic Region (2018-2023) & (Ton)
Table 29. Global Oligonucleotide API Sales Market Share Geographic Region (2018-2023)
Table 30. Global Oligonucleotide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Oligonucleotide API Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Oligonucleotide API Sales by Country/Region (2018-2023) & (Ton)
Table 33. Global Oligonucleotide API Sales Market Share by Country/Region (2018-2023)
Table 34. Global Oligonucleotide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Oligonucleotide API Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 37. Americas Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 38. Americas Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 40. Americas Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 41. Americas Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 42. APAC Oligonucleotide API Sales by Region (2018-2023) & (Ton)
Table 43. APAC Oligonucleotide API Sales Market Share by Region (2018-2023)
Table 44. APAC Oligonucleotide API Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Oligonucleotide API Revenue Market Share by Region (2018-2023)
Table 46. APAC Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 47. APAC Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 48. Europe Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 49. Europe Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 50. Europe Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 52. Europe Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 53. Europe Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 54. Middle East & Africa Oligonucleotide API Sales by Country (2018-2023) & (Ton)
Table 55. Middle East & Africa Oligonucleotide API Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Oligonucleotide API Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Oligonucleotide API Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Oligonucleotide API Sales by Type (2018-2023) & (Ton)
Table 59. Middle East & Africa Oligonucleotide API Sales by Application (2018-2023) & (Ton)
Table 60. Key Market Drivers & Growth Opportunities of Oligonucleotide API
Table 61. Key Market Challenges & Risks of Oligonucleotide API
Table 62. Key Industry Trends of Oligonucleotide API
Table 63. Oligonucleotide API Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oligonucleotide API Distributors List
Table 66. Oligonucleotide API Customer List
Table 67. Global Oligonucleotide API Sales Forecast by Region (2024-2029) & (Ton)
Table 68. Global Oligonucleotide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 70. Americas Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Oligonucleotide API Sales Forecast by Region (2024-2029) & (Ton)
Table 72. APAC Oligonucleotide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 74. Europe Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Oligonucleotide API Sales Forecast by Country (2024-2029) & (Ton)
Table 76. Middle East & Africa Oligonucleotide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Oligonucleotide API Sales Forecast by Type (2024-2029) & (Ton)
Table 78. Global Oligonucleotide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Oligonucleotide API Sales Forecast by Application (2024-2029) & (Ton)
Table 80. Global Oligonucleotide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Jazz Pharmaceuticals Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 82. Jazz Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
Table 83. Jazz Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. Jazz Pharmaceuticals Main Business
Table 85. Jazz Pharmaceuticals Latest Developments
Table 86. Sarepta Therapeutics Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 87. Sarepta Therapeutics Oligonucleotide API Product Portfolios and Specifications
Table 88. Sarepta Therapeutics Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Sarepta Therapeutics Main Business
Table 90. Sarepta Therapeutics Latest Developments
Table 91. Biogen Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 92. Biogen Oligonucleotide API Product Portfolios and Specifications
Table 93. Biogen Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Biogen Main Business
Table 95. Biogen Latest Developments
Table 96. Dynavax Technologies Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 97. Dynavax Technologies Oligonucleotide API Product Portfolios and Specifications
Table 98. Dynavax Technologies Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Dynavax Technologies Main Business
Table 100. Dynavax Technologies Latest Developments
Table 101. Akcea Therapeutics Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 102. Akcea Therapeutics Oligonucleotide API Product Portfolios and Specifications
Table 103. Akcea Therapeutics Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. Akcea Therapeutics Main Business
Table 105. Akcea Therapeutics Latest Developments
Table 106. Alnylam Pharmaceuticals Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 107. Alnylam Pharmaceuticals Oligonucleotide API Product Portfolios and Specifications
Table 108. Alnylam Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Alnylam Pharmaceuticals Main Business
Table 110. Alnylam Pharmaceuticals Latest Developments
Table 111. Nitto Denko (Avecia) Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 112. Nitto Denko (Avecia) Oligonucleotide API Product Portfolios and Specifications
Table 113. Nitto Denko (Avecia) Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Nitto Denko (Avecia) Main Business
Table 115. Nitto Denko (Avecia) Latest Developments
Table 116. Ajinomoto (GeneDesign) Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 117. Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolios and Specifications
Table 118. Ajinomoto (GeneDesign) Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Ajinomoto (GeneDesign) Main Business
Table 120. Ajinomoto (GeneDesign) Latest Developments
Table 121. RiboBio Basic Information, Oligonucleotide API Manufacturing Base, Sales Area and Its Competitors
Table 122. RiboBio Oligonucleotide API Product Portfolios and Specifications
Table 123. RiboBio Oligonucleotide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. RiboBio Main Business
Table 125. RiboBio Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oligonucleotide API
Figure 2. Oligonucleotide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide API Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Oligonucleotide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oligonucleotide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antisense Oligonucleotides API
Figure 10. Product Picture of Small Interfering RNA (siRNA) API
Figure 11. Product Picture of MiRNA API
Figure 12. Product Picture of CpG Oligonucleotides API
Figure 13. Product Picture of Others
Figure 14. Global Oligonucleotide API Sales Market Share by Type in 2022
Figure 15. Global Oligonucleotide API Revenue Market Share by Type (2018-2023)
Figure 16. Oligonucleotide API Consumed in Contract Manufacturing Organizations (CMOs)
Figure 17. Global Oligonucleotide API Market: Contract Manufacturing Organizations (CMOs) (2018-2023) & (Ton)
Figure 18. Oligonucleotide API Consumed in Pharmaceutical Companies
Figure 19. Global Oligonucleotide API Market: Pharmaceutical Companies (2018-2023) & (Ton)
Figure 20. Global Oligonucleotide API Sales Market Share by Application (2022)
Figure 21. Global Oligonucleotide API Revenue Market Share by Application in 2022
Figure 22. Oligonucleotide API Sales Market by Company in 2022 (Ton)
Figure 23. Global Oligonucleotide API Sales Market Share by Company in 2022
Figure 24. Oligonucleotide API Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Oligonucleotide API Revenue Market Share by Company in 2022
Figure 26. Global Oligonucleotide API Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Oligonucleotide API Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Oligonucleotide API Sales 2018-2023 (Ton)
Figure 29. Americas Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 30. APAC Oligonucleotide API Sales 2018-2023 (Ton)
Figure 31. APAC Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 32. Europe Oligonucleotide API Sales 2018-2023 (Ton)
Figure 33. Europe Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Oligonucleotide API Sales 2018-2023 (Ton)
Figure 35. Middle East & Africa Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 36. Americas Oligonucleotide API Sales Market Share by Country in 2022
Figure 37. Americas Oligonucleotide API Revenue Market Share by Country in 2022
Figure 38. Americas Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 39. Americas Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 40. United States Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Oligonucleotide API Sales Market Share by Region in 2022
Figure 45. APAC Oligonucleotide API Revenue Market Share by Regions in 2022
Figure 46. APAC Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 47. APAC Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 48. China Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Oligonucleotide API Sales Market Share by Country in 2022
Figure 56. Europe Oligonucleotide API Revenue Market Share by Country in 2022
Figure 57. Europe Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 58. Europe Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 59. Germany Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Oligonucleotide API Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Oligonucleotide API Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 68. Egypt Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Oligonucleotide API in 2022
Figure 74. Manufacturing Process Analysis of Oligonucleotide API
Figure 75. Industry Chain Structure of Oligonucleotide API
Figure 76. Channels of Distribution
Figure 77. Global Oligonucleotide API Sales Market Forecast by Region (2024-2029)
Figure 78. Global Oligonucleotide API Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Oligonucleotide API Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Oligonucleotide API Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Oligonucleotide API Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Oligonucleotide API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Oligonucleotide API
Figure 2. Oligonucleotide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide API Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Oligonucleotide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oligonucleotide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antisense Oligonucleotides API
Figure 10. Product Picture of Small Interfering RNA (siRNA) API
Figure 11. Product Picture of MiRNA API
Figure 12. Product Picture of CpG Oligonucleotides API
Figure 13. Product Picture of Others
Figure 14. Global Oligonucleotide API Sales Market Share by Type in 2022
Figure 15. Global Oligonucleotide API Revenue Market Share by Type (2018-2023)
Figure 16. Oligonucleotide API Consumed in Contract Manufacturing Organizations (CMOs)
Figure 17. Global Oligonucleotide API Market: Contract Manufacturing Organizations (CMOs) (2018-2023) & (Ton)
Figure 18. Oligonucleotide API Consumed in Pharmaceutical Companies
Figure 19. Global Oligonucleotide API Market: Pharmaceutical Companies (2018-2023) & (Ton)
Figure 20. Global Oligonucleotide API Sales Market Share by Application (2022)
Figure 21. Global Oligonucleotide API Revenue Market Share by Application in 2022
Figure 22. Oligonucleotide API Sales Market by Company in 2022 (Ton)
Figure 23. Global Oligonucleotide API Sales Market Share by Company in 2022
Figure 24. Oligonucleotide API Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Oligonucleotide API Revenue Market Share by Company in 2022
Figure 26. Global Oligonucleotide API Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Oligonucleotide API Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Oligonucleotide API Sales 2018-2023 (Ton)
Figure 29. Americas Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 30. APAC Oligonucleotide API Sales 2018-2023 (Ton)
Figure 31. APAC Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 32. Europe Oligonucleotide API Sales 2018-2023 (Ton)
Figure 33. Europe Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Oligonucleotide API Sales 2018-2023 (Ton)
Figure 35. Middle East & Africa Oligonucleotide API Revenue 2018-2023 ($ Millions)
Figure 36. Americas Oligonucleotide API Sales Market Share by Country in 2022
Figure 37. Americas Oligonucleotide API Revenue Market Share by Country in 2022
Figure 38. Americas Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 39. Americas Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 40. United States Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Oligonucleotide API Sales Market Share by Region in 2022
Figure 45. APAC Oligonucleotide API Revenue Market Share by Regions in 2022
Figure 46. APAC Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 47. APAC Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 48. China Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Oligonucleotide API Sales Market Share by Country in 2022
Figure 56. Europe Oligonucleotide API Revenue Market Share by Country in 2022
Figure 57. Europe Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 58. Europe Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 59. Germany Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Oligonucleotide API Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Oligonucleotide API Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Oligonucleotide API Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Oligonucleotide API Sales Market Share by Application (2018-2023)
Figure 68. Egypt Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Oligonucleotide API Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Oligonucleotide API in 2022
Figure 74. Manufacturing Process Analysis of Oligonucleotide API
Figure 75. Industry Chain Structure of Oligonucleotide API
Figure 76. Channels of Distribution
Figure 77. Global Oligonucleotide API Sales Market Forecast by Region (2024-2029)
Figure 78. Global Oligonucleotide API Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Oligonucleotide API Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Oligonucleotide API Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Oligonucleotide API Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Oligonucleotide API Revenue Market Share Forecast by Application (2024-2029)
